...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG)
【24h】

Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG)

机译:早期乳腺癌患者辅助放射治疗后的第二原发癌:丹麦乳腺癌合作组织(DBCG)的一项全国人群研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background and purpose: To analyze the long-term risk of second primary solid non-breast cancer in a national population-based cohort of 46,176 patients treated for early breast cancer between 1982 and 2007. Patients and methods: All patients studied were treated according to the national guidelines of the Danish Breast Cancer Cooperative Group. The risk of second primary cancers was estimated by Standardised incidence ratios (SIRs) and multivariate Cox regression models were used to estimate adjusted hazard ratios (HR) among irradiated women compared to non-irradiated. All irradiated patients were treated on linear accelerators. Second cancers were a priori categorized into two groups; radiotherapy-associated- (oesophagus, lung, heart/mediastinum, pleura, bones, and connective tissue) and non-radiotherapy-associated sites (all other cancers). Results: 2358 second cancers had occurred during the follow-up. For the radiotherapy-associated sites the HR among irradiated women was 1.34 (95% CI 1.11-1.61) with significantly increased HRs for the time periods of 10-14 years (HR 1.55; 95% CI 1.08-2.24) and ??15 years after treatment (HR 1.79; 95% CI 1.14-2.81). There was no increased risk for the non-radiotherapy-associated sites (HR 1.04; 95% CI 0.94-1.1). The estimated attributable risk related to radiotherapy for the radiotherapy-associated sites translates into one radiation-induced second cancer in every 200 women treated with radiotherapy. Conclusions: Radiotherapy treated breast cancer patients have a small but significantly excess risk of second cancers. ? 2013 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology.
机译:背景与目的:分析1982年至2007年间全国46,176例接受早期乳腺癌治疗的人群为基础的第二原发性实体非乳腺癌的长期风险。患者和方法:所有接受研究的患者均按照丹麦乳腺癌合作组织的国家指南。通过标准化发病率(SIR)评估第二原发癌的风险,并使用多变量Cox回归模型来估计接受辐照的妇女与未接受辐照的妇女之间的调整后的危险比(HR)。所有接受放射治疗的患者均使用线性加速器进行治疗。将第二种癌症按先验分为两类:放射治疗相关位点(食管,肺,心脏/纵隔,胸膜,骨骼和结缔组织)和非放射治疗相关位点(所有其他癌症)。结果:随访期间发生了2358次第二次癌症。对于放疗相关部位,受辐照妇女的HR为1.34(95%CI 1.11-1.61),在10-14年的时间段内HRs显着增加(HR 1.55; 95%CI 1.08-2.24)和?? 15年治疗后(HR 1.79; 95%CI 1.14-2.81)。非放射治疗相关部位的风险没有增加(HR 1.04; 95%CI 0.94-1.1)。与放疗相关部位的放疗有关的估计归因风险转化为每200名接受放疗的妇女中有一名因辐射引起的第二种癌症。结论:放射治疗的乳腺癌患者罹患第二种癌症的风险较小,但明显过高。 ? 2013 Elsevier Ireland Ltd.保留所有权利。放射疗法和肿瘤学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号